We are live on ! Find out more
CSBR icon

Champions Oncology
CSBR

18 hedge funds and large institutions have $27.3M invested in Champions Oncology in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

75% more capital invested

Capital invested by funds: $15.6M → $27.3M (+$11.7M)

29% more funds holding

Funds holding: 14 → 18 (+4)

0.16% more ownership

Funds ownership: 38.92% → 39.08% (+0.16%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
5
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TAM
Tocqueville Asset Management
New York
+$553K
2
PCM
Perkins Capital Management
Minnesota
+$495K
3
EIM
Essex Investment Management
Massachusetts
+$490K
4
Renaissance Technologies
Renaissance Technologies
New York
+$187K
5
Deutsche Bank
Deutsche Bank
Germany
+$82.2K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$1.33M
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$78K
Name Holding Trade Value Shares
Change 		Change in
Stake
BPI
1
Battery Partners IX
Massachusetts
$12.4M – – –
NMC
2
NEA Management Company
Maryland
$9.91M – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
$984K – – –
GIP
4
Granite Investment Partners
California
$886K – – –
TAM
5
Tocqueville Asset Management
New York
$729K +$553K +114,951 New
PCM
6
Perkins Capital Management
Minnesota
$653K +$495K +103,000 New
EIM
7
Essex Investment Management
Massachusetts
$646K +$490K +101,962 New
Renaissance Technologies
8
Renaissance Technologies
New York
$638K +$187K +39,000 +63%
Deutsche Bank
9
Deutsche Bank
Germany
$108K +$82.2K +17,100 New
BlackRock
10
BlackRock
New York
$104K +$78.5K +16,338 New
Commonwealth Equity Services
11
Commonwealth Equity Services
Massachusetts
$76K +$57.3K +11,910 New
SSB
12
Sandy Spring Bank
Maryland
$53K – – –
Wells Fargo
13
Wells Fargo
California
$41K +$2.4K +500 +8%
Morgan Stanley
14
Morgan Stanley
New York
$22K +$187 +39 +1%
VIMU
15
Veritas Investment Management (UK)
United Kingdom
$13K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$11K +$221 +46 +3%
UBS Group
17
UBS Group
Switzerland
$10K +$3.06K +636 +67%
IA
18
IFP Advisors
Florida
$5K +$3.37K +700 New
PA
19
Perceptive Advisors
New York
– -$1.33M -366,973 Closed
SKK
20
Shepherd Kaplan Krochuk
Massachusetts
– -$78K -21,564 Closed

CSBR Hedge Fund Activity: Q2 2018 in Review

18 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2018, worth a combined $27.3M — up 75% from $15.6M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CSBR positions and 3 closed out — a net gain of 4 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was Tocqueville Asset Management, opening a new position worth an estimated $553K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $1.33M sold.

  • 18 institutional investors held Champions Oncology (CSBR) as of Q2 2018, up from 14 in Q1 2018.
  • Funds reported $27.3M of Champions Oncology stock for Q2 2018, up 75% quarter-over-quarter.
  • 7 funds opened new Champions Oncology positions in Q2 2018 and 3 closed out, a net change of +4 holders.
  • The largest Champions Oncology buyer in Q2 2018 was Tocqueville Asset Management, an estimated $553K added.
  • The largest Champions Oncology seller in Q2 2018 was Perceptive Advisors, an estimated $1.33M sold.

Based on aggregated 13F filings for Q2 2018.